Groesbeck Investment Management Corp Amgen Inc Transaction History

Groesbeck Investment Management Corp

$94 Million
Q1 2024

A detailed history of Groesbeck Investment Management Corp transactions in Amgen Inc stock. As of the latest transaction made, Groesbeck Investment Management Corp holds 3,803 shares of AMGN stock, worth $1.26 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares

3,803

Previous 3,788 0.4%

Holding current value

$1.26 Million

Previous $1.09 Million 0.92%

% of portfolio

1.15%

Previous 1.51%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$268.87 - $324.56 $4,033 - $4,868	15 Added 0.4%	3,803 $1.08 Million
Q4 2023 Jan 31, 2024	BUY	$255.7 - $288.46 $51,140 - $57,691	200 Added 5.57%	3,788 $1.09 Million
Q3 2023 Oct 25, 2023	BUY	$218.65 - $271.46 $50,289 - $62,435	230 Added 6.85%	3,588 $964,000
Q2 2023 Jul 26, 2023	SELL	$214.27 - $253.37 $93,635 - $110,722	-437 Reduced 11.52%	3,358 $746,000
Q4 2022 Feb 01, 2023	SELL	$229.03 - $291.01 $7,328 - $9,312	-32 Reduced 0.84%	3,795 $997,000

Q2 2022 Aug 01, 2022	SELL	$230.71 - $256.74 $33,683 - $37,484	-146 Reduced 3.67%	3,827 $931,000
Q4 2021 Feb 01, 2022	BUY	$198.88 - $227.6 $41,764 - $47,796	210 Added 5.58%	3,973 $894,000
Q3 2021 Oct 27, 2021	SELL	$212.27 - $248.7 $134,791 - $157,924	-635 Reduced 14.44%	3,763 $800,000
Q2 2021 Jul 30, 2021	BUY	$233.58 - $259.14 $122,395 - $135,789	524 Added 13.53%	4,398 $1.07 Million
Q1 2021 May 05, 2021	BUY	$221.91 - $258.6 $77,668 - $90,510	350 Added 9.93%	3,874 $964,000
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $25,100 - $29,889	-116 Reduced 3.19%	3,524 $810,000
Q2 2020 Jul 06, 2020	SELL	$197.81 - $242.74 $39,166 - $48,062	-198 Reduced 5.16%	3,640 $859,000
Q1 2020 Jun 02, 2020	SELL	$182.24 - $241.7 $2.74 Million - $3.64 Million	-15,050 Reduced 79.68%	3,838 $778,000
Q4 2019 Jan 22, 2020	SELL	$189.21 - $243.2 $91,956 - $118,195	-486 Reduced 2.51%	18,888 $4.55 Million
Q3 2019 Nov 05, 2019	BUY	$174.11 - $208.62 $160,877 - $192,764	924 Added 5.01%	19,374 $3.75 Million
Q2 2019 Jul 26, 2019	SELL	$166.7 - $195.41 $17,336 - $20,322	-104 Reduced 0.56%	18,450 $3.4 Million
Q1 2019 May 03, 2019	SELL	$180.87 - $203.88 $43,589 - $49,135	-241 Reduced 1.28%	18,554 $3.53 Million
Q4 2018 Jan 25, 2019	SELL	$178.4 - $208.25 $72,430 - $84,549	-406 Reduced 2.11%	18,795 $3.66 Million
Q3 2018 Oct 18, 2018	SELL	$185.29 - $208.89 $64,295 - $72,484	-347 Reduced 1.78%	19,201 $3.98 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $36,863 - $41,405	-222 Reduced 1.12%	19,548 $3.61 Million
Q1 2018 May 02, 2018	SELL	$169.43 - $198.0 $864,093 - $1.01 Million	-5,100 Reduced 20.51%	19,770 $3.37 Million
Q4 2017 Feb 07, 2018	SELL	$168.79 - $188.59 $117,646 - $131,447	-697 Reduced 2.73%	24,870 $4.33 Million
Q3 2017 Oct 16, 2017	BUY	$167.29 - $191.0 $4.28 Million - $4.88 Million	25,567	25,567 $4.77 Million

Others Institutions Holding AMGN

# of Institutions

2,959

Shares Held

402M

Call Options Held

6.59M

Put Options Held

6.61M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $177B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Groesbeck Investment Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Groesbeck Investment Management Corp with notifications on news.

Account

Groesbeck Investment Management Corp Amgen Inc Transaction History